KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Exchange Rate Effect (2016 - 2025)

Novavax has reported Exchange Rate Effect over the past 13 years, most recently at -$1.7 million for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$1.7 million for Q4 2025, up 84.05% from a year ago — trailing twelve months through Dec 2025 was $5.9 million (up 175.96% YoY), and the annual figure for FY2025 was $5.9 million, up 175.96%.
  • Exchange Rate Effect for Q4 2025 was -$1.7 million at Novavax, down from $658000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for NVAX hit a ceiling of $9.3 million in Q3 2023 and a floor of -$10.7 million in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was $251000.0 (2024), compared with a mean of $31250.0.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 2311.52% in 2021 and later skyrocketed 5167.95% in 2025.
  • Novavax's Exchange Rate Effect stood at $916000.0 in 2021, then soared by 365.39% to $4.3 million in 2022, then tumbled by 31.57% to $2.9 million in 2023, then tumbled by 467.4% to -$10.7 million in 2024, then surged by 84.05% to -$1.7 million in 2025.
  • The last three reported values for Exchange Rate Effect were -$1.7 million (Q4 2025), $658000.0 (Q3 2025), and $7.9 million (Q2 2025) per Business Quant data.